Gretai:6499

Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device

TAIPEI, Jan. 27, 2021 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign...

2021-01-27 17:41 860

Medeon Led and Completed Investments in Panther Orthopedics and Prodeon

TAIPEI, , July 8, 2019 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon. Panther Orthopedics is a Silicon Valley startup company pioneerin...

2019-07-08 17:10 12994

Medeon Entering Asset Purchase Agreement with Terumo for its Large Bore Vascular Closure System

TAIPEI, , March 5, 2018 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce today that it entered into a definitive asset purchase agreement withTokyo -based Terumo Corporation (TSE: 4543) for its large bore vascular closure ...

2018-03-05 15:00 539